Ruth Alon
Director/Board Member chez ALPHA TAU MEDICAL LTD.
Fortune : - $ au 31/03/2024
Profil
Ruth Alon is the founder of NetVision Ltd.
(1993), Israel Advanced Technology Industries (2012), and Medstrada Ltd.
(2016), where she holds the title of Chief Executive Officer & Director.
Ms. Alon's current positions include Chairman at TransPharma Medical Ltd., Chairman at BrainsGate Ltd., Director at APOS Medical Israel Ltd., Director at CarboFix Orthopedics Ltd., Director at 330 Avenue Medical Health PC, Director at BioRap Technologies Ltd., Independent Director at Alpha Tau Medical Ltd.
(starting in 2022), Director at Treos Bio Ltd.
(starting in 2021), Director at Phoska Biopharma Pte Ltd., Independent Director at Moringa Acquisition Corp., and BRD at Fibronostics US, Inc. Ms. Alon's former positions include Co-Chairman at Kadimastem Ltd.
(2020-2021), Independent External Director at Anchiano Therapeutics Ltd., Director at HealOr Ltd., Director at Proneuron Biotechnologies, Inc., Independent Non-Executive Director at Vascular Biogenics Ltd.
(2010-2023), Director at BlueTree Technologies Ltd.
(2020-2022), Principal at Montgomery Securities, Inc., Principal at Kidder Peabody (1987-1993), and General Partner at Pitango Venture Capital (1997-2016).
Ms. Alon's education includes an MBA from Boston University, an undergraduate degree from The Hebrew University of Jerusalem, and a graduate degree from Columbia University College of Physicians & Surgeons.
Ms. Alon is also the founder of Israel Life Science Industry.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ALPHA TAU MEDICAL LTD
-.--% | 01/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Ruth Alon
| Sociétés | Poste | Début |
|---|---|---|
| MORINGA ACQUISITION CORP | Director/Board Member | - |
| ALPHA TAU MEDICAL LTD. | Director/Board Member | 21/03/2022 |
TransPharma Medical Ltd.
 TransPharma Medical Ltd. Pharmaceuticals: MajorHealth Technology Established in 2000, TransPharma Medical Ltd. is a specialty pharmaceutical company focused on the development and commercialization of drug-products utilizing an innovative active transversal drug delivery technology. Its current proprietary drug-product development programs include ViaDerm-hPTH (1-34), a transversal hPTH (1-34) product to treat osteoporosis, undergoing Phase 2B clinical trials, which is developed in collaboration with Eli Lilly, and two additional peptides currently in Phase 1. TransPharma's drug-product development activities utilize its well-proven RF-MicroChannel Technology. Its RF-MicroChannel technology enables the creation of an array of microscopic pores through the very outer skin surface, allowing the delivery of therapeutic doses of a wide portfolio of drugs, including biologics, Its main area of focus. TransPharma's implementation of the RF-MicroChannel Technology is the ViaDerm delivery system. Intended for home use, the ViaDerm delivery system consists of a reusable, handheld, low-cost device and a disposable patch containing a drug. TransPharma's goal is to develop multiple drug-products through strategic partnerships with leading pharmaceutical companies and through independent product development. They believe that combining partnered and proprietary product development ensures capitalizing of both the promise of its technology and its growing capabilities. | Chairman | - |
Phoska Biopharma Pte Ltd.
 Phoska Biopharma Pte Ltd. BiotechnologyHealth Technology Phoska Biopharma Pte Ltd. develops advancing new therapies for treating liver and metabolic conditions. The company is headquartered in Singapore. | Director/Board Member | - |
Treos Bio Ltd.
 Treos Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Treos Bio Ltd. engages in the development of a digital cancer vaccine technology platform that provides tailored precision vaccines to patients. It focuses on cancer immunotherapies. The company was founded by john Kenneth Hautman and Julianna Lisziewicz in 2013 and is headquartered in London, the United Kingdom. | Director/Board Member | 01/06/2021 |
BioRap Technologies Ltd.
 BioRap Technologies Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Technion-Israel Institute of Technology, BioRap Technologies Ltd. is an Israeli bio-pharmaceutical company that engages in research, development, and commercialization of drugs. The private company is based in Haifa, Israel. | Director/Board Member | - |
CarboFix Orthopedics Ltd.
 CarboFix Orthopedics Ltd. Electronic Equipment/InstrumentsElectronic Technology CarboFix Orthopedics Ltd. engages in the development, manufacture, and marketing of solutions for trauma and spine. Its products include CarboClear cervical plate, CarboClear pedicle screw, proximal humerus plate, CarboClear lumbar cage, and distal fibula plate. The company was founded Mordechay Beyar in 2011 and is headquartered in Herzliya, Israel. | Director/Board Member | - |
| Medstrada Ltd. | Founder | 01/01/2016 |
330 Avenue Medical Health PC
 330 Avenue Medical Health PC Medical SpecialtiesHealth Technology 330 Avenue Medical Health PC develops, manufactures, and distributes orthopedics and sports medicines. The firm offers treatments include knee pain (osteoarthritis, patello-femoral, meniscal tear, and ligament tear), lower back pain, hip pain (osteoarthritis), and ankle problems (post fractures and recurrent ankle sprain). The company was founded by Avi Elbaz and Amith Mor in 2004 and is headquartered in New York, NY. | Director/Board Member | - |
| ░░░░ ░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Anciens postes connus de Ruth Alon
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Ruth Alon
| Boston University | Masters Business Admin |
| The Hebrew University of Jerusalem | Undergraduate Degree |
| Columbia University College of Physicians & Surgeons | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| KADIMASTEM LTD | Health Technology |
| ALPHA TAU MEDICAL LTD. | Health Technology |
| MORINGA ACQUISITION CORP | Finance |
| Entreprise privées | 21 |
|---|---|
Anchiano Therapeutics Ltd.
 Anchiano Therapeutics Ltd. BiotechnologyHealth Technology Anchiano Therapeutics Ltd. is a clinical-stage biopharmaceutical company, which engages in tin the discovery, development and commercialization of drugs for cancer-related diseases. Its products include two drugs for cancer BC-819 and BC-821. The company was founded by Avraham Hochberg in 2004 and is headquartered in Jerusalem, Israel. | Health Technology |
| Montgomery Securities, Inc. | Finance |
| Kidder Peabody | Finance |
Pitango Venture Capital
 Pitango Venture Capital Investment ManagersFinance Pitango Venture Capital (Pitango) is a venture capital firm founded in 1993 by Rami Kalish. The firm is headquartered in Herzliya, Israel. | Finance |
NetVision Ltd.
 NetVision Ltd. Internet Software/ServicesTechnology Services NetVision Ltd. operates in the communication sector of international telephony services in Israel. The company offers communication solutions and services among which Internet and international calls for organizations, businesses and private users. It also offers information security services, hosting services, anti-virus services, website filtering and telephony products and services using cutting-edge technological solutions. NetVision was founded by Alon Zvi and is headquartered in Haifa, Israel. | Technology Services |
TransPharma Medical Ltd.
TransPharma Medical Ltd. Pharmaceuticals: MajorHealth Technology Established in 2000, TransPharma Medical Ltd. is a specialty pharmaceutical company focused on the development and commercialization of drug-products utilizing an innovative active transversal drug delivery technology. Its current proprietary drug-product development programs include ViaDerm-hPTH (1-34), a transversal hPTH (1-34) product to treat osteoporosis, undergoing Phase 2B clinical trials, which is developed in collaboration with Eli Lilly, and two additional peptides currently in Phase 1. TransPharma's drug-product development activities utilize its well-proven RF-MicroChannel Technology. Its RF-MicroChannel technology enables the creation of an array of microscopic pores through the very outer skin surface, allowing the delivery of therapeutic doses of a wide portfolio of drugs, including biologics, Its main area of focus. TransPharma's implementation of the RF-MicroChannel Technology is the ViaDerm delivery system. Intended for home use, the ViaDerm delivery system consists of a reusable, handheld, low-cost device and a disposable patch containing a drug. TransPharma's goal is to develop multiple drug-products through strategic partnerships with leading pharmaceutical companies and through independent product development. They believe that combining partnered and proprietary product development ensures capitalizing of both the promise of its technology and its growing capabilities. | Health Technology |
HealOr Ltd.
 HealOr Ltd. Pharmaceuticals: MajorHealth Technology HealOr Ltd. develops and commercializes proprietary biochemical regulatory therapeutics impacting skin cells properties for the purpose of treating various skin pathologies. Its leading drug, HO/03/03, is currently undergoing Phase II/III clinical trials in the United States and India. The company is also establishing a first-in-class therapeutic pipeline for additional skin pathologies such as chronic and acute wounds, dry skin, acne, psoriasis, and others. HealOr was founded by Tamar Tennenbaum in 2002 and is headquartered in Rechovot, Israel. | Health Technology |
Proneuron Biotechnologies, Inc.
 Proneuron Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Proneuron Biotechnologies, Inc. develops therapies for nervous disorders. The company develops therapies for neurological, ophthalmologic and immune-related disorders such as spinal cord injuries, multiple sclerosis, glaucoma, Parkinson's disease and Alzheimer's diseases. It was founded in 1996 and is headquartered in New York, NY. | Health Technology |
Vascular Biogenics Ltd.
 Vascular Biogenics Ltd. BiotechnologyHealth Technology Vascular Biogenics Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of next-generation, targeted medicines for difficult-to-treat medical conditions. Its product candidates are built off of its platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel. | Health Technology |
BrainsGate Ltd.
 BrainsGate Ltd. Medical SpecialtiesHealth Technology BrainsGate Ltd. develops medical devices. The firm specializes in therapies for patients suffering from central nervous system diseases. Its platform technology involves electrical stimulation of the Spheno-Palatine Ganglion, a nervous center known to increase cerebral blood flow. The company was founded by Yossi Gross and David Yarnitsky in 2000 and is headquartered in Caesarea, Israel. | Health Technology |
| Israel Life Science Industry | |
APOS Medical Israel Ltd.
 APOS Medical Israel Ltd. Medical/Nursing ServicesHealth Services APOS Medical Israel Ltd. is a holding company that provides non-surgical medical treatment services for musculoskeletal disorders. It offers AposTherapy, a non-surgical and drug-free medical program for knee and back pain, which utilizes an individually calibrated, foot-worn biomechanical device. The firm's program treats body's mal-alignment, muscle weakness, impaired neuromuscular control, and the resulted abnormal pathological movement patterns of orthopaedic conditions. The company was founded by Avi Elbaz and Amit Mor in 2004 and is headquartered in Herzliya Pituach, Israel. | Health Services |
Israel Advanced Technology Industries
 Israel Advanced Technology Industries Miscellaneous Commercial ServicesCommercial Services Israel Advanced Technology Industries is an umbrella organization that represents the high-tech, life science, and other advanced technology industries. The private company is based in Hertzliya Pituach, Israel. The Israeli company was founded by Nechemia Jacob Peres, Aaron Mankovski, and Ruth Alon. The CEO is Karin Meir Rubinstein. | Commercial Services |
CarboFix Orthopedics Ltd.
CarboFix Orthopedics Ltd. Electronic Equipment/InstrumentsElectronic Technology CarboFix Orthopedics Ltd. engages in the development, manufacture, and marketing of solutions for trauma and spine. Its products include CarboClear cervical plate, CarboClear pedicle screw, proximal humerus plate, CarboClear lumbar cage, and distal fibula plate. The company was founded Mordechay Beyar in 2011 and is headquartered in Herzliya, Israel. | Electronic Technology |
330 Avenue Medical Health PC
330 Avenue Medical Health PC Medical SpecialtiesHealth Technology 330 Avenue Medical Health PC develops, manufactures, and distributes orthopedics and sports medicines. The firm offers treatments include knee pain (osteoarthritis, patello-femoral, meniscal tear, and ligament tear), lower back pain, hip pain (osteoarthritis), and ankle problems (post fractures and recurrent ankle sprain). The company was founded by Avi Elbaz and Amith Mor in 2004 and is headquartered in New York, NY. | Health Technology |
BioRap Technologies Ltd.
BioRap Technologies Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Technion-Israel Institute of Technology, BioRap Technologies Ltd. is an Israeli bio-pharmaceutical company that engages in research, development, and commercialization of drugs. The private company is based in Haifa, Israel. | Commercial Services |
Fibronostics US, Inc.
 Fibronostics US, Inc. Packaged SoftwareTechnology Services Fibronostics US, Inc. operates healthcare technology company, which develops algorithms to detect disease and monitor progression. The firm provides platform that develops non-invasive algorithm based diagnostics to improve treatment outcomes, facilitate screening of specific diseases and help prognosis in various chronic conditions. The company was founded in 2015 and is headquartered in Orlando, FL. | Technology Services |
| Medstrada Ltd. | Miscellaneous |
Treos Bio Ltd.
Treos Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Treos Bio Ltd. engages in the development of a digital cancer vaccine technology platform that provides tailored precision vaccines to patients. It focuses on cancer immunotherapies. The company was founded by john Kenneth Hautman and Julianna Lisziewicz in 2013 and is headquartered in London, the United Kingdom. | Commercial Services |
Phoska Biopharma Pte Ltd.
Phoska Biopharma Pte Ltd. BiotechnologyHealth Technology Phoska Biopharma Pte Ltd. develops advancing new therapies for treating liver and metabolic conditions. The company is headquartered in Singapore. | Health Technology |
BlueTree Technologies Ltd.
 BlueTree Technologies Ltd. Beverages: Non-AlcoholicConsumer Non-Durables BlueTree Technologies Ltd. is a foodtech company based in Kiryat Shmona, Israel. BlueTree's proprietary technology and system physically and selectively reduces sugar content (up to 50%%) from 100%% squeezed natural orange juice, making it natural, healthy, and tasty. The Israeli company's technology and system offer several significant benefits to the natural juice industry, including reduced sugar, improved blending properties, and improved reduced storage and distribution. BlueTree is the first "graduate" of the FreshStart Food Tech Incubator, partnered by Tnuva, Tempo, OurCrowd, and Finistere Ventures, and is one of the leading players in the thriving northern food tech ecosystem. The company was founded by Yuval Klein and Didier Toubia, and Michael Gordon has been the CEO of the company since 2022. | Consumer Non-Durables |
